There is an urgent need to improve the clinical management of major depressive disorder (MDD), which has become increasingly prevalent over the past two decades. Several gaps and challenges in the awareness, detection, treatment, and monitoring of MDD remain to be addressed. Digital health technolo...
Activity tracker health monitoring anxiety disorders depressive disorder general practice; 37.Apps and wearables for monitoring physical activity and sedentary behaviour: A qualitative systematic review protocol on barriers and facilitators 机译:用于监视体育活动和久坐行为的应用程序和可穿戴设备:关于障碍和促进者...
The Patient-Health-Questionnaire (PHQ-8), a validated instrument for the assessment of depressive disorders, provided an initial evaluation of sleep disturbance [30,31,32]. The inclusion criteria for the main ‘SOMNUS’-study were initially adult patients with histologically confirmed cancer. Then ...
Major depressive disorderCognitivebehavioral therapyVirtual realityAI and ChatbotsBiofeedbackSerious gamesThe chapter provides an in-depth analysis of digital therapeutics (DTx) as a revolutionary approach to managing major depressive disorder (MDD). It discusses the evolution and definition of DTx, their ...
The use of digital health applications (German acronym DiGA) for comprehensive patient care is increasing rapidly. Patients with non-organic insomnia can be prescribed an application to manage insomnia. Due to the high prevalence of insomnia in patients
More information:Kovtun O, Rosenthal SJ. Seasonality in mood disorders: Probing association of accelerometer-derived physical activity with daylength and solar insolation,PLOS Mental Health(2024).DOI: 10.1371/journal.pmen.0000124 Provided by
deprexis is a web application indicated for the adjunctive treatment of chronic or recurrent depression or depressive disorders as a primary or secondary diagnosis (e.g. as a comorbidity in multiple sclerosis or epilepsy) for patients 18 years of age or older who are experiencing a depressive epis...
during the COVID-19 pandemic was analyzed to estimate changes in subjective well-being and clinical improvement in depressive symptoms (using the World Health Organization-Five [WHO-5] Well-Being Index), as well as compare the relative effectiveness and cost of different care utilization patterns....
Dr. Joseph F Hayes, Professor at UCL and Chief Medical Officer of juli said “The study's success is a testament to the power of technology and research collaboration. juli, an AI-driven app, supports individuals with chronic cond...
This can be used to distinguish whether the positive healthcare effect should be demonstrated for all patients with a specific disorder (e.g., F32.-Depressive Episode) or for a specific patient population (e.g., F32.0-Mild Depressive Episode). If several indications are given, the evidence ...